SecBot SecBot
COURT-RULING ·Filed Jul 10, 2026

NVO

NOVO NORDISK A S
NEUTRAL
Impact 2/10
Horizonmonths Processed3mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

This is a routine procedural extension with no market-moving information. Monitor the August 10, 2026 status report for any settlement announcement or case progression that could reveal material terms.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
NVO ▼ -23.84% at T+60d
NEUTRAL call -23.84% · α vs SPY -27.84% · entry $49.28 → $37.53
Entry = T+0 close
Jul 13, 2026
via day close
T+1d
-0.43%
call -0.43% · α -0.78%
$49.07
settled 4mo ago
T+5d
+0.67%
call +0.67% · α +1.61%
$49.61
settled 3mo ago
T+20d
-3.15%
call -3.15% · α -6.33%
$47.73
settled 3mo ago
T+60d
-23.84%
call -23.84% · α -27.84%
$37.53
settled 22d ago

Price Chart

Loading chart...

Executive Summary

The court granted a fourth joint stipulation to stay discovery in Novo Nordisk's case against Aesthetic Center of Plastic Surgery, extending the stay through August 10, 2026, as parties continue settlement negotiations. This procedural order is routine and indicates ongoing settlement discussions with no material financial exposure or business impact disclosed.

Court Ruling Details

Ruling Date
Jul 10, 2026
Court
United States District Court for the District of North Dakota
Court Level
District
Judge
Clare R. Hochhalter
Case Type
other
Ruling Type
procedural
Outcome
OTHER
Precedent Risk
LOW

Key Facts

  • Parties filed fourth Joint Stipulation to Stay Discovery, indicating ongoing settlement discussions
  • Discovery stay extended through August 10, 2026
  • Parties must submit joint status report by August 10, 2026
  • No damages, injunction, or financial exposure mentioned in the order
  • Routine procedural order — no substantive ruling on merits

Financial Impact

No financial impact disclosed; case involves undisclosed claims with no damages awarded or pleaded in this order

Risk Factors

  • Settlement terms, if any, are unknown and could involve undisclosed financial obligations
  • If settlement fails, case proceeds to litigation with potential discovery costs and reputational risk

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
35% bullish (37 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-8c305ad3e0-NVO
35 reports for NVO
Performance horizon
83% Hit rate @ T+20 5 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +23.56%Jul 28, 2026
Filters
Rows
Reports for NVO — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
6-K
NEUTRAL ★ 2/10
$39.13awaiting T+20—$38.67 (−1.18%)
Oct 26, 2026
2d ago
Court Ruling
NEUTRAL ★ 4/10
$38.59awaiting T+20—$38.67 (+0.21%)
Oct 19, 2026
8d ago
6-K
NEUTRAL ★ 2/10
$38.42awaiting T+20—$38.67 (+0.65%)
Oct 13, 2026
14d ago
6-K
NEUTRAL ★ 2/10
$38.06awaiting T+20—$38.67 (+1.60%)
Oct 6, 2026
21d ago
6-K
NEUTRAL ★ 2/10
$37.53awaiting T+20—$38.67 (+3.04%)
Sep 28, 2026
29d ago
6-K
NEUTRAL ★ 2/10
$38.71 $38.95▲ +0.61%▲ +0.64%$38.67 (−0.10%)
Sep 23, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$38.62 $39.43▲ +2.10%▲ +2.52%$38.67 (+0.13%)
Sep 21, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$39.80 $38.42▼ −3.47%▼ −2.56%$38.67 (−2.84%)
Sep 17, 2026
5w ago
6-K
BULLISH ★ 6/10
$43.19 $39.22▼ −9.19%▼ −10.40%$38.67 (−10.47%)
Sep 15, 2026
6w ago
6-K
NEUTRAL ★ 3/10
$42.53 $38.06▼ −10.51%▼ −13.23%$38.67 (−9.08%)
Showing 10 of 35

US Market Status

Market Closed — Opens Thu (11h 50m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Jul 11, 2026